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Abstract: 
Cytochrome P450s are superfamily of heme proteins which generally monooxygenate hydrophobic compounds. The human 
cytochrome P450 4F22 (CYP4F22) was categorized into “orphan” CYPs because of its unknown function. CYP4F22 is a potential 
drug target for cancer therapy. However, three-dimensional structure, the active site topology and substrate specificity of CYP4F22 
remain unclear. In this study, a three-dimensional model of human P450 4F22 was constructed by comparative modeling using 
Modeller 9v5. The resulting model was refined by energy minimization, subjected to the quality assessment from both geometric 
and energetic aspects and was found to be of reasonable quality. Docking approach was employed to dock arachidonic acid into 
the active site of CYP4F22 in order to probe the ligand-binding modes. As a result, several key residues were identified to be 
responsible for the binding of arachidonic acid with CYP4F22. These findings provide useful information for understanding the 
biological roles of CYP4F22 and structure-based drug design. 
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Background: 
Cytochromes P450 (CYP) which are a superfamily of heme 
containing enzymes play an important  role in detoxification 
and metabolic activation of large number of xenbiotic chemicals 
such as drugs, carcinogens and many endogenous compounds 
like hormones and vitamins. There are 57 CYP isoenzymes 
found in humans which are well-known for their 
monooxgenase reaction. However, one quarter of the CYP 
family remains orphan, which means that their function, 
expression studies and substrate information are not yet clearly 
understood. Thirteen members of this superfamily are classified 
as orphans by Guengerich [1].  
 
Human CYP4F22 was considered as one such orphan CYPs, 
amino acid sequence of which has been identified recently.  The 
three-dimensional structure of this protein is not yet known. 
Experimental studies of CYP4 family members are previously 
reported to metabolize arachidonic acid (AA) [2] like 
endogenous compounds to its hydroxyl product. CYP family 
members were found to share their substrates with one another. 
CYP4F22 gene as a part of a cluster of cytochrome P450 genes 
on chromosome 19 encodes an enzyme thought to play a role in 
the 12(R)-lipoxygenase pathway. Mutation in this gene is the 
cause of ichthyosis lamellar type 3. It was recently found that 
CYP4F22 was specifically expressed in human breast cancer 
tissues. For this reason, human CYP4F22 has been suggested to 
be a potential drug target for cancer therapy. However, to date, 
information regarding the structure and ligand binding site is 
not available for CYP4F22 and hence structural information 
might help us to understand the ligand interaction.  
 
In this study, a 3D model of CYP4F22 was constructed using 
comparative modeling method, followed by energy 
minimization to refine the initial model. The quality of the BIOINFORMATION  open access 
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resulting 3D model of P450 4F22 was critically assessed through 
geometric and energetic assessments. After that, arachidonic 
acid (AA) was docked into the active site of the proposed 3D 
structure of CYP4F22 and certain key residues responsible for 
substrate specificity were identified.  Further 2D QSAR study 
was used to find out the pharmacological characteristics of the 
ligand. The results obtained in this study will be useful for 
further elucidation of the biological role and the structure-based 
drug design of P450 4F22. 
 
Methodology: 
Sequence retrieval 
The protein sequence (531 amino acids) of human CYP4F22 was 
obtained from the UniProtKB database (accession number: 
Q6NT55).  
 
Template identification and sequence alignment 
For template selection, BlastP [3] search was used against 
Protein DataBank (PDB). The templates having high similarity 
were selected for the model building. The templates were 
aligned and examined for conserved sequence with the target 
by ClustalW [4].  
 
Comparative modeling of human CYP4F22 
The alignment was used as the input and the homology model 
of P450 2F22 was generated using Modeller 9v5 [5].  Loops were 
modeled using ModLoop server [6]. The coordinates for heme 
were obtained from 1TQN and positioned as in the template.  
 
Energy minimization and structural quality assessment 
The resulting model was further refined by energy 
minimization using the Amber9 package [7] and subjected to 
quality assessment. The Procheck [8] and Verify 3D [9] were 
utilized for geometric evaluation.  The Prosa [10] was employed 
to examine the energy of residue-residue interactions using a 
distance-based pair potential approach. The energy was 
transformed to a score called z-score where residues with 
negative z-score indicate reasonable side-chain interactions. The 
final model was then submitted to the protein modeling 
database [11] as PM0077605. 
 
2D QSAR study: 
The selected ligand arachidonic acid (AA) is a long-chain fatty 
acid with a hydrophobic tail. The arachidonic acid was 
downloaded from Pubchem in Structure Data Format (SDF). 
Conversion of SDF to Protein Data Bank (PDB) format was 
carried out using Swiss PDB viewer. The molecular structure of  
ligand was optimized using the Polak-Ribiere algorithm until 
the root mean square gradient was 0.01 kcal mol-1 using 
Hyperchem V 8.09 [12]. The molecular descriptors were 
calculated for the ligand using QSAR properties of Hyperchem.  
 
Prediction of key residues in homology model of CYP4F22: 
The homology model of CYP4F22 was submitted to automated 
ConSurf web server [13] for the identification of functional 
regions of CYP4F22 by estimating the degree of conservation of 
the amino-acid sites among their close sequence homologues. 
 
Molecular docking of CYP4F22-ligand complex: 
Both the modeled protein and ligand were optimized using 
“dock prepare” of the USCF chimera [14]. The optimized ligand 
molecule was docked into the refined CYP4F22 protein model 
using Hex software [15]. The molecular graphical 
representation was prepared using Pymol program [16].  
 
 
Figure 1: Multiple sequence alignment of target 
(CYP4F22:Q6NT55) and two templates (1W0E and 1TQN) 
represented using ClustalW Program. The alignment figure was 
prepared using Espript 2.2. The red colour indicates the 
residues conserved in all three sequences. 
 
Results and Discussion: 
The first step in homology modeling is to detect appropriate 
template proteins whose structures are known that are expected 
to be similar to the target protein. A BlastP search confirmed 
that there are several mammalian CYPs structures which could 
serve as potential templates for P450 4F22 modeling. The top-
ranked two templates are 1W0E [17] and 1TQN [18]. The 
sequence conservation and the signature motifs of CYP4F22 
were examined using multiple sequence alignment with 
templates (Figure 1). The essential signature motif FxGxxxCxG 
is characteristic motif for the CYP superfamily which includes a 
conserved cystine residue that ligates to the Fe of the heme. The 
amino acid sequence identity between target and the templates 
was above 40% which is high enough to construct a 3D model. 
The initial 3D model of CYP4F22 was energy-minimized and 
assessed for both geometric and energy aspects. The Procheck 
evaluation for good stereochemistry of the refined model 
resulted in 97.8% in the allowed regions and 2.1% in disallowed 
regions. Verify 3D analysis resulted in a model with about 81% 
of residues with a score over 0.2, indicating a good model. The 
Prosa analysis showed that z-score in the CYP4F22 model was 
negative in most residues, further indicating a reliable model. 
The 3D structure model of CYP4F22 exhibits a fold similar to 
those of other P450s and contains the heme group sandwiched 
between helices (Figure 2a). CYP4F22 model of this study also 
reveals that a highly conserved threonine is located in the 
middle of helix I which is similar to other reported human CYP 
structures. This conserved residue has been suggested to 
participate in the protein delivery and play an important role in 
the dioxygen bond cleavage during the catalytic cycle [19]. The 
CYP4F22 model was further tested using ConSurf server for the 
prediction of active residues (Figure 2b) that are expected to be 
accessible, either at the surface or in a pocket of the protein. The BIOINFORMATION  open access 
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functional residues of CYP4F22 model with high conservation 
scores were identified Table 1 (see supplementary material). 
The energy minimized model of arachidonic acid was also 
subjected to 2D QSAR study using Hyperchem. Topological 
(surface area of 603.66 Å2) and constitutional descriptors (LogP 
of 10.10, molecular weight of 303.46 amu, polarizability of 36.83 
Å3 and refractivity of 62.82 Å3) were computed and found to be 
desirable pharmacological characteristics for docking. To 
determine the key residues responsible for ligand interaction, 
the homology model of CYP4F22 was docked with arachidonic 
acid (Figure 2c). The free energy of binding (ΔGbind kcal/mol) 
for the designed ligand was found to be -3.53 kcal/mol. The 
negative and low value of ΔGbind indicates a strong favorable 
bond between CYP4F22 protein and the AA ligand in most 
favorable conformations. Several important residues were 
detected in homology model of P450 4F22. The residue ARG 156 
appears to play an important role in substrate specificity. The 
corresponding TRP 152 and THR 160 pairs were conserved and 
they were directly in contact with ligands. In addition, the rest 
of the ligand-interacting residues GLY 471, CYS 475, ILE 476and 
GLN 478 were mostly located near the key residues (Figure 2d).  
 
 
Figure 2: (a) Ribbon schematic representation of the homology 
model of CYP4F22. The heme is shown in the center of the 
figure in red stick. Various visible regions of secondary 
structure elements are labeled in the figure, (b) Predicted active 
sites of CYP4F22, (c) 2D structure of arachidonic acid and (d) a 
close view of CYP4F22 with arachidonic acid. Key residues are 
shown in red spheres and labeled. The substrate arachidonic 
acid is shown as grey stick. 
Conclusion: 
The human P450 4F22 theoretical 3D model was constructed 
using homology modeling, refined with energy minimization 
and assessed for sterochemical and energetic aspects. Docking 
approaches were employed to dock arachidonic acid ligand into 
the active site of the proposed 3D model in order to probe 
ligand binding modes. The docking studies as well as the 
ConSurf analysis revealed the important residues involved in 
the substrate specificity. The docking and ConSurf analysis are 
in concurrence with each other reflecting the importance of 
crucial residues. Interacting key residues gave information on 
the substrate specificity of the CYP4F22 active site when they 
interact with arachidonic acid ligand of hydrophobicity. Also 
these residues might act as ligand-channeling and could help 
the reaction center of the protein. The current results might be 
very helpful for the determination of biological role to provide 
insights into arachidonic acid. 
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Supplementary material: 
 
Table 1: Function regions of CYP4F22 predicted using ConSurf server with high amino acid conservation score (9 - conserved, 1 - 
variable).  
Residue Conservation  score Buried (B)/Exposed (E)  Residual variety 
G149 9  E  G 
D150 5  E  N,  D,  E 
K151 9  E  K 
W152 8  E  W 
S153 4  E  S,  N,  G 
R154 3  E  H,S,Q,R 
H155 9  B  H 
R156 9  B  R 
R157 9  E  R 
L158 4  B  M,  L 
L159 9  B  L 
T160 9  B  T 
S469 9  E  S 
A470 9  E  A 
G471 9  B  G 
P472 9  E  P 
R473 9  E  R 
N474 9  E  N 
C475 9  B  C 
I476 9  B  I 
G477 9  B  G 
Q478 9  E  Q 
S479 3  B  A,S,T,N 
F480 9  B  F 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 